Venous Thromboembolism Market
According to Intent Market Research, the Venous Thromboembolism Market is expected to grow from USD 1.8 billion in 2024-e at a CAGR of 10.9% to touch USD 3.4 billion by 2030. The Venous Thromboembolism Market is dominated by key players such as, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, and Bayer AG.